The migraines changed when the estrogen stopped being predictable

Migraine

5 min read

The headaches changed and nobody named what changed about them. Different timing, different location, different warning signs. The most widely cited explanation is the estrogen withdrawal hypothesis: a sharp decline in estrogen can trigger an attack. During perimenopause, the speed and frequency of those declines become unpredictable, and the migraine pattern follows.

The pattern shifted. You noticed because you live inside it. The research has mapped how estrogen instability during perimenopause changes the frequency, timing, and character of migraine, and what you are describing is consistent with what the population data show.

A 2015 systematic review by Ripa and colleagues in the International Journal of Women’s Health examined 22 studies on migraine and menopause. Population-based studies showed a tendency toward improvement after natural menopause, when estrogen settles at lower but stable levels. During perimenopause, the pattern was different: prevalence remained stable or increased. The review noted that studies performed in headache clinics showed no improvement or even worsening, but attributed this to selection bias, as women whose migraines worsened were more likely to seek specialist care.

A 2025 narrative review in BMJ Sexual and Reproductive Health traced the connection through a neuropeptide called CGRP (calcitonin gene-related peptide). When estrogen levels are high and stable, estrogen may limit CGRP signaling, lowering the likelihood of an attack. When estrogen declines or fluctuates, as it does unpredictably during perimenopause, there is a shift toward increased CGRP activity. CGRP is the target of several newer migraine therapies, including erenumab, fremanezumab, and galcanezumab, making this an active area of clinical research.

What it does not establish

The estrogen-CGRP connection is supported by converging evidence in women as a group. No study can establish it as the cause in any individual. Migraine has multiple triggers, and the relative contribution of hormonal instability compared with sleep disruption, medication overuse, and other factors cannot be determined from population data. The estrogen withdrawal hypothesis explains timing, not the full picture of why some women develop migraine and others with the same hormonal profile do not.

The estrogen-CGRP pathway

Estrogen modulates CGRP signaling in the trigeminovascular system, the network involved in migraine pain. When estrogen is high and stable, CGRP activity is suppressed. When estrogen drops sharply, CGRP release increases and the threshold for an attack falls. During perimenopause, the timing and magnitude of estrogen fluctuations become erratic, which may explain why migraine patterns change in ways that do not follow the predictable monthly cycle they once did.

The numbers

10% to 29%

Prevalence of migraine in menopausal women across the 22 studies included in the Ripa 2015 systematic review. Population-based studies showed improvement after natural menopause. Clinic-based studies showed stable or worse migraine, which the review attributed to selection bias.

17%

Of postmenopausal women in one clinic-based study who reported that their migraine began in the postmenopausal period, with no prior history of migraine. The study was small (47 women) and clinic-based. But the finding is notable: the pattern can start in this window, not only change.

The range is wide because the studies measured different populations in different ways. What is consistent across them is the direction: perimenopause is the volatile window, and natural menopause, when estrogen levels settle at low but stable concentrations, is more often associated with improvement. The instability, not the decline itself, is what the convergent evidence points to.

The intervention with the strongest evidence

A structured headache diary

Recommended by clinical guidelines

Multiple clinical headache guidelines recommend that patients keep a headache diary to monitor frequency, intensity, triggering factors, and medication use. Two weeks of structured data gives a clinician a record of what changed, when it changed, and what preceded each attack. This is particularly important when the pattern has shifted, because general recollection compresses months of change into vague impressions that are difficult to act on.

“Keeping track of your migraine symptoms can help manage migraine. Gathering this information will help you better communicate with your doctor and stay on top of warning signs.”

American Headache Society

What it is not

A treatment for migraine. The diary does not reduce attack frequency on its own. It is a structured observation that gives your clinician data to work with, especially when the pattern has changed and you cannot describe the change precisely from memory. It replaces guessing with counting.

When to call

New onset headache after age 50 is a red flag in multiple clinical guidelines. This does not mean it is dangerous. It means new headache in this age group requires assessment to rule out secondary causes, including temporal arteritis, for which ESR and CRP blood tests should be checked.

A thunderclap headache, one that reaches peak intensity within seconds to minutes, requires emergency evaluation regardless of age or migraine history.

A substantial change in the pattern or character of an existing headache, including increased frequency, new aura, or headache that wakes you from sleep, warrants medical assessment even if you have had migraines for years.

This week

Start a headache diary today. For each headache, record the date, time of onset, duration, pain level on a scale of one to ten, location on the head, and any aura or warning signs. Note what you took and whether it helped.

For each entry, add what happened in the preceding 24 hours: how you slept, what you ate, your stress level, and your menstrual status if you are still cycling. The pattern often becomes visible only when the context is written down.

Bring the diary to your next appointment after two weeks. Two weeks of structured data is more useful to a clinician than years of general recollection, especially when the pattern has changed.

The migraines shifted because the signal shifted. The estrogen withdrawal hypothesis says the drop triggers the attack, and perimenopause made the drops unpredictable. You cannot control the signal, but you can record what it does. A diary, kept for two weeks, gives the person treating you something more than a description. It gives them a pattern.

One tap, no form

What changed about your headaches?

Each option opens a short prepared reply. Nothing you tap is public. What most readers tap shapes what gets explained next.

The timing changed and I cannot predict them anymore

They got worse in the past two years

I never had migraines before and they started now

None of these, but something changed

Or write in your own words. Every reply is read.

Read recent issues

Every source read for this issue

Two systematic reviews, one narrative review, one physiological review, and one professional body document.

1	Migraine in menopausal women: a systematic review Systematic review, Int J Womens Health, 2015

2	Understanding migraine throughout a woman’s life and the role of CGRP: a narrative review Narrative review, BMJ Sexual and Reproductive Health, 2025

3	Sex Differences in Migraine: Bridging Pathophysiology and Treatment Physiological review, Advances in Physiology Education, 2025

4	Patterns of Migraine in Postmenopausal Women: A Systematic Review Systematic review, Neuropsychiatr Dis Treat, 2021

5	Changes in Headache: When to See Your Doctor Professional body document, American Headache Society

Read more from The Cortisol Effect